A comparative study of the role of disease severity in drug reimbursement decision making in four European countries

Considerations beyond cost-effectiveness are important in reimbursement decision making. We assessed the importance of disease severity in drug reimbursement decision making in Belgium, France, The Netherlands and Sweden. We investigated scientific literature and policy documents and conducted three interviews in each country (four in The Netherlands) with persons involved in drug reimbursement. Disease severity is an important consideration, especially where the level is high. The Netherlands operationalizes disease severity using the proportional shortfall approach. Sweden uses categories to... Mehr ...

Verfasser: Franken, Margreet
Stolk, Elly
Scharringhausen, Tessa
de Boer, Anthonius
Koopmanschap, Marc
Dokumenttyp: Artikel
Erscheinungsdatum: 2015
Schlagwörter: Disease severity / Medical need / Drug reimbursement / Health policy / Belgium / France / The Netherlands / Sweden / Taverne
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26573766
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dspace.library.uu.nl/handle/1874/428239